Maruyama D, Iida S, Ogawa G, Fukuhara N , Seo S, Miyazaki K, Yoshimitsu M, Kuroda J, Tsukamoto N, Tsujimura H, Hangaishi A, Yamauchi T, Utsumi T, Mizuno I, Takamatsu Y, Nagata Y, Minauchi K, Ohtsuka E , Hanamura I, Yoshida S, Yamasaki S, Suehiro Y, Kamiyama Y, Tsukasaki K, Naga H. Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105). Br J Haematol. 2021 Feb;192(3):531-541. doi: 10.1111/bjh.16878. Epub 2020 Jun 24. https://pubmed.ncbi.nlm.nih.gov/32583431/
Ohmachi K, Kinoshita T, Tobinai K, Ogawa G, Mizutani T , Yamauchi N, Fukuhara N, Uchida T , Yamamoto K , Miyazaki K, Tsukamoto N, Iida S , Utsumi T , Yoshida I, Imaizumi Y , Tokunaga T , Yoshida S , Masaki Y , Murayama T , Yakushijin Y, Suehiro Y , Nosaka K, Dobashi N , Kuroda J, Takamatsu Y, Maruyama D , Ando K, Ishizawa K , Ogura M , Yoshino T, Hotta T, Tsukasaki K, Nagai H, Japan Clinical Oncology Group A. randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial. Blood Adv. 2021 Feb 23;5(4):984-993. doi: 10.1182/bloodadvances.2020002567. https://pubmed.ncbi.nlm.nih.gov/33591324/
Taniguchi S, Yamauchi T , Choi I , Fukuhara N , Potluri J , Salem H.A. , Hong-W-H , Honda H, Nishimura Y , Okubo S, Usuki K. Venetoclax in combination with azacitidine in Japanese patients with acute myeloid leukaemia: phase 1 trial findings. Jpn J Clin Oncol. 2021 May 28;51(6):857-864. doi: 10.1093/jjco/hyab018. https://pubmed.ncbi.nlm.nih.gov/33712849/
Kawai H , Ando K , Maruyama F , Yamamoto K , Kiyohara E , Terui Y , Fukuhara N, Miyagaki T , Tokura Y , Yanagimoto-S -M , Igarashi T , Kuroda J , Fujita J , Uchida T , Ishikawa T, Yonekura K, Kato K , Nakanishi T , Nakai K , Matsunaga R, Tobinai K. Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma. Cancer Sci. 2021 Jun;112(6):2426-2435. doi: 10.1111/cas.14906. Epub 2021 May 3. https://pubmed.ncbi.nlm.nih.gov/33792128/
Terui Y, Rai S , Izutsu K, Yamaguchi M , Takizawa J, Kuroda J, Ishikawa T , Kato K , Suehiro Y, Fukuhara N, Ohmine K, Goto H, Yamamoto K, Kanemura N, Ueda Y, Ishizawa K, Kumagai K, Kawasaki A , Saito T , Hashizume M, Shibayama H. A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphoma. Cancer Sci. 2021 Jul;112(7):2845-2854. doi: 10.1111/cas.14937. Epub 2021 Jun 4. https://pubmed.ncbi.nlm.nih.gov/33942442/
Onodera K, Onishi Y, Inoue J, Tanaka Y, Yonha L, Ichikawa S, Fukuhara N, Yokoyama H, Murai K, Masamune A, Harigae H. Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case report. J Infect Chemother. 2021 Aug;27(8):1230-1233. doi: 10.1016/j.jiac.2021.02.002. Epub 2021 Feb 12. https://pubmed.ncbi.nlm.nih.gov/33589371/
Hirasawa T, Kikuchi M, Shigeta K, Takasaki S , Sato Y , Sato T, Ogura J, Onodera K, Fukuhara N, Onishi Y , Maekawa M, Mano N. High-throughput liquid chromatography/electrospray ionization-tandem mass spectrometry method using in-source collision-induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma. Biomed Chromatogr. 2021 Aug;35(8):e5124. doi: 10.1002/bmc.5124. Epub 2021 Apr https://pubmed.ncbi.nlm.nih.gov/33772839/
Ichikawa S, Fujiwara T, Saito K, Sakurai K, Inokura K, Fukuhara N, Yokoyama H, Onodera K, Onishi Y, Kameoka J, Harigae H. Salvage Cord Blood Transplantation for Sustained Remission of Acute Megakaryoblastic Leukemia That Relapsed Early after Myeloablative Transplantation. Intern Med. 2021 Sep 15;60(18):3015-3019. doi: 10.2169/internalmedicine.6796-20. Epub 2021 Apr https://pubmed.ncbi.nlm.nih.gov/33814495/
Ichikawa S, Furukawa E, Saito K, Fukuhara N, Onodera K, Onishi Y, Yokoyama H, Ichinohasama R ,Harigae H. Sustained remission of giant pancreatic plasmacytoma with daratumumab. Ann Hematol. 2021 Oct;100(10):2633-2634. doi: 10.1007/s00277-020-04145-9. Epub 2020 Jun 18. https://pubmed.ncbi.nlm.nih.gov/32556544/
Ichikawa S, Fujiwara T, Saito K, Fukuhara N, Yokoyama H, Hatta S, Onodera K, Onishi Y, Fujishima F, Ichinohasama R, Harigae H. A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis. Ann Hematol. 2021 Oct;100(10):2665-2668. doi: 10.1007/s00277-020-04241-w. Epub 2020 Aug 31. https://pubmed.ncbi.nlm.nih.gov/32865606/
Fujishima F, Fukuhara N, Katsushima H, Nakamura Y, Harigae H, Sasano H, Ichinohasama R. Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells. BMC Cancer. 2021 Dec 20;21(1):1352. doi: 10.1186/s12885-021-09098-4. https://pubmed.ncbi.nlm.nih.gov/34930176/
Ichikawa S, Fukuhara N, Hashimoto K, Fujishima F, Ichinohasama R, Harigae H. Anaplastic multiple myeloma with MYC rearrangement. Leuk Res Rep. 2021 Dec 27;17:100288. doi: 10.1016/j.lrr.2021.100288. eCollection 2022. https://pubmed.ncbi.nlm.nih.gov/35024332/
Ri M, Iida S, Maruyama D, Sakabe A, Kamei R, Nakashima T, Tohkin M, Osaga S, Tobinai K , Fukuhara N, Miyazaki K, Tsukamoto N, Tsujimura H, Yoshimitsu M, Miyamoto K, Tsukasaki K, Nagai H. HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1). Cancer Sci. 2021 Dec;112(12):5011-5019. doi: 10.1111/cas.15158. Epub 2021 Oct https://pubmed.ncbi.nlm.nih.gov/34626515/